VISTA
Anualidades
Lista
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
TOTAL Nº PUBLICACIONES:
27
PUBLICACIONES EN REVISTAS
Bastos-Oreiro, M, Gutierrez, A, Iacoboni, G, Corral, LL, Reguera, JL, Abrisqueta, P, Delgado, J, Terol, MJ, Hernani, R, Martínez, N, Ortíz, V, Bailen, R, Gomez-Centurión, I, Caballero, A, Sanz, J, Domínguez, LG, Luzardo, H, Mussetti, A, Jiménez-Ubieto, A, Sancho, JM, Sureda, A, Pérez, A, Barba, P, Kwon, M, García-Sancho, AM.
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/ GETH Study.
TRANSPL CELL THER 29 -. 1 dic 2023. 1 nov 2023. . F.I.:3,600
[doi:10.1016/j.jtct.2023.08.026]
Rejeski, K, Wang, YC, Albanyan, O, Munoz, J, Sesques, P, Iacoboni, G, Lopez-Corral, L, Ries, I, Buecklein, Veit L. L., Mohty, R, Dreyling, M, Baluch, A, Shah, BJ, Locke, FL, Hess, G, Barba, P, Bachy, E, Lin, Y, Subklewe, M, Jain, MD.
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
AM J HEMATOL 98 1699-1710. 1 nov 2023. 1 ago 2023. . F.I.:10,100
[doi:10.1002/ajh.27056]
Cortés-Rodríguez, M, Galindo-Villardón, P, Sánchez-Barba, M, Jarauta-Bragulat, E, Urchaga-Litago, JD.
Analysis of Psychological Well-Being from a Compositional Data Analysis Perspective: A New Approach.
BEHAV SCI-BASEL 13 -. 1 nov 2023. . . F.I.:2,500
[doi:10.3390/bs13110926]
Cabrero, M, Cortes, M, Perez-Lopez, E, Martin, AA, Cabero, A, Baile, M, Avendaño, A, Garcia-Bacelar, A, de Ramon, C, Acera, M, Vazquez, L, Sanchez-Guijo, F, Lopez-Corral, L.
RETROSPECTIVE ANALYSIS AND COMPARISON OF SINUSOIDAL OBSTRUCTION SYNDROME DIAGNOSIS CRITERIA: CAN WE ANTICIPATE DIAGNOSIS?.
BONE MARROW TRANSPL 58 518-519. 1 nov 2023. . . F.I.:4,500
Rodríguez-Arbolí, E, Lee, CJ, Caballero-Velázquez, T, Martínez, C, García-Calderón, C, Jiménez-León, MR, Bermúdez-Rodríguez, MA, López-Corral, L, Triguero, A, Onstad, L, Horwitz, ME, Sarantopoulos, S, Lee, SJ, Pérez-Simón, JA.
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials.
CLIN CANCER RES 29 4057-4067. 13 oct 2023. . . F.I.:10,000
[doi:10.1158/1078-0432.CCR-23-0666]
Oliva-Ariza, G, Fuentes-Herrero, B, Lecrevisse, Q, Carbonell, C, Pérez-Pons, A, Torres-Valle, A, Pozo, J, Martín-Oterino, JA, González-López, O, López-Bernús, A, Bernal-Ribes, M, Belhassen-García, M, Pérez-Escurza, O, Pérez-Andrés, M, Vazquez, L, Hernández-Pérez, G, Garcia Palomo, Francisco Javier, Leoz, P, Costa-Alba, P, Pérez-Losada, E, Yeguas, A, Santos Sanchez, Miryam, García-Blázquez, M, Morán-Plata, FJ, Damasceno, D, Botafogo, V, Munoz-Garcia, Noemi, Fluxa, R, van Dongen, JJM, Marcos, M, Almeida, J, Orfao, A.
Immune cell kinetics and antibody response in COVID-19 patients with low-count monoclonal B-cell lymphocytosis.
AM J HEMATOL 98 1909-1922. 4 oct 2023. 1 oct 2023. . F.I.:10,100
[doi:10.1002/ajh.27119]
Pinana, Jose Luis, Heras, I, Aiello, TF, García-Cadenas, I, Vazquez, L, Lopez-Jimenez, J, Chorao, P, Aroca, C, García-Vidal, C, Arroyo, I, Soler-Espejo, E, López-Corral, L, Avendano-Pita, Alejandro, Arrufat, A, Garcia-Gutierrez, V, Arellano, E, Hernández-Medina, L, González-Santillana, C, Morell, J, Hernández-Rivas, JA, Rodriguez-Galvez, P, Mico-Cerdá, M, Guerreiro, M, Campos, D, Navarro, D, Cedillo, A, Martino, R, Solano, C, Infect Complications Subcomm Spa.
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
VIRUSES-BASEL 15 -. 1 oct 2023. . . F.I.:3,800
[doi:10.3390/v15102066]
Puertas, B, Alejo, E, Rey-Búa, B, Dosantos, Y, Redondo, E, Real, I, Prieto, L, Ubeda, SG, Sánchez, AH, Corral, LL, Garcia-Sanz, R, Puig, N, Gonzalez-Calle, V, Mateos, MV.
Triple class refractory multiple myeloma: eficacy of the new immunotherapies and new unmet medical need.
CL LYMPH MYELOM LEUK 23 205-206. 1 sep 2023. . . F.I.:2,700
Gómez-Vecino, A, Corchado-Cobos, R, Blanco-Gómez, A, García-Sancha, N, Castillo-Lluva, S, Martín-García, A, Mendiburu-Eliçabe, M, Prieto, C, Ruiz-Pinto, S, Pita, G, Velasco-Ruiz, A, Patino-Alonso, C, Galindo-Villardón, P, Vera-Pedrosa, ML, Jalife, J, Mao, JH, de Plasencia, GM, Castellanos-Martín, A, Sáez-Freire, MD, Fraile-Martín, S, Rodrigues-Teixeira, T, García-Macías, C, Galvis-Jiménez, JM, García-Sánchez, A, Isidoro-García, M, Fuentes, M, García-Cenador, MB, García-Criado, FJ, García-Hernández, JL, Hernández-García, MA, Cruz-Hernández, JJ, Rodríguez-Sánchez, CA, García-Sancho, AM, Pérez-López, E, Pérez-Martínez, A, Gutiérrez-Larraya, F, Cartón, AJ, García-Sáenz, JA, Patino-Garcia, A, Martín, M, Alonso-Gordoa, T, Vulsteke, C, Croes, L, Hatse, S, Van Brussel, T, Lambrechts, D, Wildiers, H, Chang, H, Holgado-Madruga, M, González-Neira, A, Sánchez, PL, Losada, JP.
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.
CELLS-BASEL 12 -. 1 ago 2023. . . F.I.:5,100
[doi:10.3390/cells12151956]
Oliver-Caldés, A, González-Calle, V, Cabanas, Valentin, Espanol-Rego, Marta, Rodríguez-Otero, P, Reguera, JL, López-Corral, L, Martin-Antonio, B, Zabaleta, A, Inogés, S, Varea, S, Rosinol, Laura, de Cerio, ALD, Tovar, N, Jiménez, R, López-Parra, M, Rodríguez-Lobato, LG, Sánchez-Salinas, A, Olesti, E, Calvo-Orteu, M, Delgado, J, Pérez-Simón, JA, Paiva, B, Prósper, F, Sáez-Peñataro, J, Juan, ME, Moraleda, JM, Mateos, MV, Pascal, M, Urbano-Ispizua, A, de Larrea, CF.
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CART-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA- HCB-01): a single-arm, multicentre, academic pilot study.
LANCET ONCOL 24 913-924. 1 ago 2023. 1 ago 2023. . F.I.:41,600
[doi:10.1016/S1470-2045(23)00222-X]
Previous
1
2
3
Next
Nº de Artículos por página:
10
25
50
100